Chimeric antigen receptor T-cell (CAR-T) therapy, whereby autologous T cells are genetically engineered to recognize and eliminate tumor cells in vivo, has revolutionized cancer care since the first ...

During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...

Chimeric antigen receptor T cells (CAR-Ts) targeted against CD19 have shown impressive activity in patients with B-cell leukemias and lymphomas. This has revolutionized the treatment landscape for ...

Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR ...

During a live event, Matthew Lunning, DO, and participants discussed how identifying primary refractory and early relapsed ...

chimeric antigen receptor 1 Articles . CRISPR Could Fry All Cancer Using Newly Found T-Cell. January 27, 2020 by Kristina Panos 36 Comments . One of the human body’s greatest features is its ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.

To the Editor: Garfall et al. (Sept. 10 issue)1 describe an interesting case of a patient with multiple myeloma who was successfully treated with autologous stem-cell transplantation followed by in ...